Bennett M R (1998) Monoaminergic synapses and schizophrenia: 45 years of neuroleptics. J Psychopharmacol12: 289-304
2.
Busatto G F, Kerwin R W (1997) Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J Psychopharmacol11: 3-12
3.
Farde L, Nordstrom A L, Wiesel F A, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central Di and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatr49: 538-544
4.
Lahti R A, Roberts R C, Conley R R, Cochrane E V, Mutin A, Tamminga C A (1996) D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. Neuroreport7:1945-1948
5.
Murray A M, Hyde T M, Knable M B, Heramn M M, Bigelow L B, Carter J M, Weinberger D R, Kleinman J E (1995) Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci15: 2186-2191
6.
Reynolds G P (1996) The importance of dopamine D4 receptors in the action and development of antipsychotic agents. Drugs51: 7-11
7.
Reynolds G P, Mason S L (1995) Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. Eur J Pharmacol281: R5-R6
8.
Roberts D A, Balderson D, Pickering-Brown S M, Deakin J F W, Owen F (1996) The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls. Schiz Res20: 171-174
9.
Robertson G S, Matsumura H, Fibiger H C (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther271: 1058-1066
10.
Seeman P, Tallerico T (1998) Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiat3: 123-134
11.
Seeman P, Guan H-C, Van Tol H H M (1993) Dopamine D4 receptors elevated in schizophrenia. Nature365: 441-445
12.
White F J, Wang R Y (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science221:1054-1057
